News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,489 Results
Type
Article (12448)
Company Profile (33)
Press Release (251006)
Multimedia
Podcasts (21)
Webinars (3)
Section
Business (76728)
Career Advice (1080)
Deals (14631)
Drug Delivery (40)
Drug Development (35496)
Employer Resources (39)
FDA (6151)
Job Trends (5892)
News (130209)
Policy (9690)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
Academia (793)
Academic (1)
Accelerated approval (27)
ADA (25)
Adcomms (17)
Allergies (127)
Alliances (10457)
ALS (119)
Alzheimer's disease (846)
Antibody-drug conjugate (ADC) (340)
Approvals (6678)
Artificial intelligence (374)
ASCO (255)
Autoimmune disease (228)
Automation (33)
Bankruptcy (97)
Best Places to Work (5208)
BIOSECURE Act (2)
Biosimilars (151)
Biotechnology (22)
Bladder cancer (172)
Brain cancer (42)
Breast cancer (589)
Cancer (4174)
Cardiovascular disease (328)
Career advice (861)
Career pathing (12)
CAR-T (187)
CDC (15)
Celiac Disease (1)
Cell therapy (510)
Cervical cancer (44)
Clinical research (34140)
Collaboration (1160)
Company closure (2)
Compensation (1505)
Complete response letters (28)
COVID-19 (1030)
CRISPR (62)
C-suite (550)
Cystic fibrosis (80)
Data (5993)
Decentralized trials (1)
Denatured (1)
Depression (95)
Dermatology (64)
Diabetes (389)
Diagnostics (2708)
Digital health (30)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (184)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (180)
Earnings (60792)
Editorial (20)
Employer branding (5)
Employer resources (34)
Events (43922)
Executive appointments (558)
FDA (8619)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (22)
Funding (960)
Gene editing (127)
Generative AI (21)
Gene therapy (378)
GLP-1 (634)
Government (1483)
Grass and pollen (5)
Guidances (378)
Healthcare (7549)
Hematology (114)
HIV (69)
Huntington's disease (28)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (74)
Immunology and inflammation (199)
Immuno-oncology (65)
Indications (141)
Infectious disease (1219)
Inflammatory bowel disease (130)
Inflation Reduction Act (4)
Influenza (72)
Intellectual property (108)
Interviews (196)
IPO (9344)
IRA (16)
Job creations (999)
Job search strategy (749)
JPM (19)
Kidney cancer (17)
Labor market (62)
Layoffs (206)
Leadership (16)
Legal (1743)
Liver cancer (61)
Longevity (9)
Lung cancer (601)
Lymphoma (358)
Machine learning (29)
Management (13)
Manufacturing (476)
MASH (153)
Medical device (5467)
Medtech (5547)
Mergers & acquisitions (6136)
Metabolic disorders (1010)
mRNA (76)
Multiple sclerosis (120)
NASH (9)
Neurodegenerative disease (252)
Neuropsychiatric disorders (65)
Neuroscience (1751)
NextGen: Class of 2026 (2282)
Non-profit (1504)
Now hiring (25)
Obesity (458)
Opinion (92)
Ovarian cancer (130)
Pain (131)
Pancreatic cancer (183)
Parkinson's disease (214)
Partnered (9)
Patents (213)
Patient recruitment (386)
Peanut (48)
People (10741)
Pharmaceutical (12)
Pharmacy benefit managers (14)
Phase 1 (9469)
Phase 2 (14618)
Phase 3 (12892)
Pipeline (6868)
Policy (65)
Postmarket research (1270)
Preclinical (3262)
Press Release (14)
Prostate cancer (233)
Psychedelics (26)
Radiopharmaceuticals (175)
Rare diseases (666)
Real estate (1186)
Recruiting (17)
Regulatory (9414)
Reports (30)
Research institute (786)
Resumes & cover letters (199)
Rett syndrome (37)
RNA editing (12)
RSV (66)
Schizophrenia (127)
Series A (149)
Series B (119)
Service/supplier (2)
Sickle cell disease (76)
Special edition (15)
Spinal muscular atrophy (67)
Sponsored (18)
Startups (847)
State (1)
Stomach cancer (8)
Supply chain (66)
Tariffs (27)
The Weekly (20)
Vaccines (530)
Venture capital (49)
Weight loss (307)
Women's health (58)
Worklife (5)
Date
Today (51)
Last 7 days (235)
Last 30 days (1594)
Last 365 days (19069)
2026 (9617)
2025 (19423)
2024 (18405)
2023 (17837)
2022 (21574)
2021 (22717)
2020 (20350)
2019 (17973)
2018 (12802)
2017 (12137)
2016 (10411)
2015 (12724)
2014 (9078)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (302)
Alabama (34)
Alaska (1)
Arizona (121)
Arkansas (7)
Asia (15931)
Australia (2433)
California (9214)
Canada (2122)
China (939)
Colorado (347)
Connecticut (372)
Delaware (338)
Europe (37600)
Florida (1039)
Georgia (215)
Hawaii (3)
Idaho (21)
Illinois (709)
India (48)
Indiana (358)
Iowa (13)
Japan (458)
Kansas (62)
Kentucky (25)
Louisiana (40)
Maine (43)
Maryland (919)
Massachusetts (6558)
Michigan (163)
Minnesota (401)
Mississippi (4)
Missouri (92)
Montana (15)
Nebraska (8)
Nevada (97)
New Hampshire (58)
New Jersey (2312)
New Mexico (14)
New York (2119)
North Carolina (920)
North Dakota (3)
Northern California (4735)
Ohio (228)
Oklahoma (8)
Oregon (16)
Pennsylvania (1540)
Puerto Rico (10)
Rhode Island (21)
South America (449)
South Carolina (22)
Southern California (3625)
Tennessee (111)
Texas (1339)
United States (30070)
Utah (182)
Vermont (1)
Virginia (193)
Washington D.C. (34)
Washington State (720)
West Virginia (2)
Wisconsin (112)
263,489 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCardia Announces $4.4 Million Financing
June 8, 2026
·
2 min read
Layoffs
Takeda’s ‘transformation program’ leaves 4,500 jobless
While Takeda is eliminating 4,500 roles across its global operations, the company has some 2,200 jobs currently open for hiring, for which internal candidates will be prioritized.
May 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 19, 2026
June 21, 2026
·
2 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 4, 2026
June 5, 2026
·
1 min read
Press Releases
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - June 4, 2026
June 5, 2026
·
1 min read
Press Releases
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 4, 2026
June 5, 2026
·
1 min read
Press Releases
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - June 4, 2026
June 5, 2026
·
1 min read
Press Releases
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 21, 2026
May 22, 2026
·
2 min read
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 18, 2026
May 18, 2026
·
1 min read
Drug Development
4 troubled targets that have thwarted biopharma
The tragic tale of TIGIT is well known. However, RIPK1, myc, STING and alpha-synuclein have also left a trail of failed clinical trials, canceled partnerships and sunk investments in their wake.
May 26, 2026
·
9 min read
·
Tristan Manalac
1 of 26,349
Next
